Masayuki Tsuchiya

A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells.

M. Oheda, Koji Otabe, Y. Kikuchi, 2004, Biochemical and biophysical research communications.

Determination of concentration and binding affinity of antibody fragments by use of surface plasmon resonance.

M. Nanami, Y. Kikuchi, N. Fukushima, 2005, Journal of bioscience and bioengineering.

Establishment and characterization of in vivo human tumor models in the NOD/SCID/γcnull mouse

N. Tamaoki, Y. Ohnishi, K. Adachi, 2008, Pathology international.

A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand

A. Murakami, Kanako Wakabayashi-Nakao, T. Yanagisawa, 2022, The Journal of biological chemistry.

Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics

Miwa Sato, Y. Matsunaga, Kanako Wakabayashi-Nakao, 2022, Antibodies.

Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma.

Yasufumi Kikuchi, Yasushi Yoshimura, Hisafumi Yamada-Okabe, 2005, Leukemia research.

An Evolutionarily Conserved Motif in the TAB1 C-terminal Region Is Necessary for Interaction with and Activation of TAK1 MAPKKK*

J. Ninomiya-Tsuji, Kunihiro Matsumoto, N. Hisamoto, 2001, The Journal of Biological Chemistry.

VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody.

T. Igawa, H. Tsunoda, Y. Sekimori, 2010, Protein engineering, design & selection : PEDS.